better used for the estimation of the serum calcium several times in every patient with calcareous renal stones.
Discussion: It may be difficult to distinguish the milk alkali syndrome from primary hyperparathyroidism, as many hyperparathyroid patients have peptic ulcers and have been taking milk and alkali for long periods. The two diseases may resemble each other closely in their biochemical features, including the response of the hypercalcxmia to cortisone. I have investigated 5 patients with peptic ulcers, hypercalcwmia and azotxmia. Three of them were found to have parathyroid adenomata when their necks were explored. One has had his neck explored without a parathyroid adenoma being found, but is still thought to have hyperparathyroidism because the exploration was followed by an abrupt but transient drop in serum calcium and blood urea levels. The fifth patient had a negative exploration and the hypercalcTrmia gradually fell over the following six months, but reappeared when he went back to a diet containing milk. Milk alkali syndrome appears to be very rare in comparison with hyperparathyroidism.
The low serum phosphorus occurring in some patients with steatorrheea is usually explained as being due to secondary hyperparathyroidism. I have had a patient of this type who had a serum calcium of 4-5 mg% and a serum phosphorus of 1*7 mg%. This patient came to autopsy and despite careful search no parathyroid tissue was -found. This does not entirely exclude parathyroid hyperplasia but makes it unlikely, and suggests the possibility that there is some other explanation for the hypophosphatemia in these patients.
Mr G L Fordyce (Northwood, Middlesex) pointed out that the initial sign of hyperparathyroidism was occasionally found in the mouth in the form of an epulis which might grow with extreme rapidity, simulating a sarcomatous lesion. He described briefly 3 cases of this type.
Dr Oliver Garrod (London) asked if there was any correlation between the severity of the patients' symptoms and the level of serum calcium.
Professor C E Dent, in reply to this question, said that he thought there was very little, but that each patient had a very exact threshold for symptoms. (London) This paper describes some results obtained using the immunological assay for growth hormone (GH) in human serum described by Read & Stone (1958) and Read (1960) . The results shown are averages of 3 assays done on separate days and the variation has usually lain well within 50 pg each side of the mean.
The assay values in 19 normal subjects, apart from one low value, were found to lie between 100 and 480 pg/l. The mean of the group is 257 (S.D. = 137). A few subjects have been studied over periods of time from two days to one year as shown in Fig 1 4) . Follow-up studies on treatment with thyroid in 2 cases have shown a fall in the assays, which reached the normal range after two months. Further studies on this group of patients are in progress. Read (1960) and Hartog & Fraser (1961) have found significantly raised GH levels in active acromegaly, compared with their range for normal of 88 to 256 ,ug/l. Seven of our assays on acromegalics would be considered raised by these workers. However, 5 of these assays lie within our normal range, even though 3 of them are active cases.
Various possible explanations for our failure to demonstrate a significantly raised assay in active acromegaly can be considered. The presence of Should GH in acromegaly differ from that in normals, it might be more sensitive to handling or altered in some way in vivo so as to lose, or partly lose, its immunological activity and thus fail to be fully detected in the assay. If this were so one could also postulate the formation of an antibody to GH which would reduce the titre in acromegalic sera. However no prozone of agglutination has been noted with the higher concentrations of these sera during the assays, so that this explanation is thought to be unlikely.
Another approach to the problems has been to consider whether the rate of utilization differs results obtained are shown in Fig 5. The values of serum GH within half an hour of injection rose in a normal subject, and in 2 hypopituitary and 2 myxcedemic subjects by from 300 to 1,500 pg/l., and the levels fell within six to twelve hours to the known basal values. The levels obtained declined with half life of 2-25 hours in the normal and 2-13 and 2-6 hours in the hypopituitary subjects. Neither of the myxcedemic patients had a high basal assay so that the finding of half lives of 1 85 and 3 5 hours, neither of which is significantly different from the others, is of interest, but further cases must be studied before any comment on the raised levels in some cases of myxcedema can be made.
Two acromegalic patients were given 3 mg ofGH intravenously. In one, an active case, no rise could be found in the 5-minute sample. In the other, A M R. hypopit 0 L.R. hypopit X P.S myxcedema * R M msxcedema * R L. normal probably inactive, the assay level rose from 120 to 160 ,ug in three minutes after the injection, but fluctuated between these levels over the day. This doubtful rise cannot be compared to that seen in the other subjects. There being no obvious technical reason for these findings it is possible that there is some alteration in handling of GH or at least of exogenous GH in acromegaly.
From these results it appears that we are unable to assess activity in cases of acromegaly or gigantism by the assay of GH levels in the serum. More cases of acromegaly of well-defined activity must be studied before one can say whether the handling of a load of GH may distinguish the active cases. At present the assay is most reliable in distinguishing cases of hypopituitarism.
Immunoassay of Growth Hormone in Human Serum
An immunological assay for growth hormone in human serum employing hemagglutination inhibition has recently been described by Read (1960) . The method of assay depends upon the fact that erythrocytes coated with human growth hormone (HGH) prepared by the method of Raben (1959) are agglutinated by rabbit anti-HGH serum and that prior addition of a definite quantity of HGH to the antiserum will inhibit such agglutination. When a constant amount of antiserum and serial dilutions of HGH or human serum is employed, the HGH content of the serum may readily be calculated.
Experimental procedure: Sheep erythrocytes were treated with tannic acid as described by Read (1960) and then suspended in a solution containing 10 ,ug/ml of HGH prepared by the method of Raben (1959) from human pituitary glands obtained at autopsy. For assay of HGH, 0 1 ml of a 1 % suspension of HGH-coated erythrocytes, 0-1 ml of serial dilutions of human serum (1: 2 to I : 80) or of HGH (0 075 to 0 005 pg/ml) and 0 -ml of an appropriate dilution of antiserum were mixed in small round-bottomed tubes of as uniform a shape as possible and run in duplicate. The diluent in each case was normal rabbit serum (1: 150 in 0-15M phosphate buffer pH 7 2). The tubes were allowed to stand at room temperature for four to twelve hours and the presence or absence of agglutination defined by the pattern of settling (Stavitsky 1954) . Since the titre of antiserum was found to vary by a small but significant amount each day it was particularly important to measure the titre of the antiserum immediately before each assay. The final dilution of antiserum employed was approximately the titre. In normal pregnancy the serum concentration of HGH was found to be within the normal range. In successive trimesters the concentrations were 22 5+2 8 (8 subjects) 20 7± 1 2 (15 subjects) and 19 2+1 7 (13 subjects). On the other hand, in 10 patients studied two to ten days post partum the mean HGH concentration was found to be increased (mean 36±4-4; range 21-66).
Comment: These results confirm the conclusion of Read (1960) that an immunological assay for HGH based on hmmagglutination inhibition can be successfully applied to the estimation of HGH in serum. The values which have been obtained for serum of normal adults are very similar to those of Read but lower than those reported by McGarry et al. (1960) . Our findings also confirm that the serum concentration of HGH may be increased in some cases of acromegaly and reduced in hypophysectomized patients. The finding of values within the normal range for serum HGH concentration in 6 of 10 patients hypophysectomized by surgery or irradiation could be explained if these patients had sufficient residual pituitary tissue to maintain near normal serum HGH concentrations. Recent work of Campbell (1959) has emphasized the functional significance of minute amounts of pituitary tissue remaining after hypophysectomy.
